Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma

Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s interface revision/version has been updated from **v3.5.2** to **v3.5.3**. No study record content or clinical information appears to change with this revision marker.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.2 to the record history and removed the v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    A new site revision entry appears: v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:09:08.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a minor page update with no visible changes to study information.
    Difference
    0.1%
    Check dated 2026-03-12T02:23:49.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the history. The funding-status notice and the older Revision: v3.4.1 entry were removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:38:26.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide operating-status notice about government funding and operations, and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:41:30.000Z thumbnail image

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma

Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.